These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 36567441)
21. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer. Chen LT; Liu TW; Wu CW; Chung TR; Shiah HS; Jan CM; Liu JM; Whang-Peng J; Chang JY Oncology; 2002; 63(3):239-47. PubMed ID: 12381903 [TBL] [Abstract][Full Text] [Related]
22. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer. Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346 [TBL] [Abstract][Full Text] [Related]
23. Salvage chemotherapy with biweekly irinotecan, plus 5-fluorouracil and leucovorin in patients with advanced gastric cancer previously treated with fluoropyrimidine, platinum, and taxane. Sym SJ; Ryu MH; Lee JL; Chang HM; Kim TW; Lee SS; Lee JS; Kang YK Am J Clin Oncol; 2008 Apr; 31(2):151-6. PubMed ID: 18391599 [TBL] [Abstract][Full Text] [Related]
24. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways. Xu GY; Tang XJ Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805 [TBL] [Abstract][Full Text] [Related]
25. [A case of advanced gastric cancer with multiple bone metastasis successfully treated by both methotrexate and 5-fluorouracil sequential therapy, and endoscopic intratumoral injection of 5-fluorouracil]. Sasahara K; Uchida Y; Kamei M; Matsuda K; Kawabata H; Nishioka M Gan To Kagaku Ryoho; 1998 Jan; 25(1):121-4. PubMed ID: 9464338 [TBL] [Abstract][Full Text] [Related]
26. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema MR; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco AR Br J Cancer; 2005 May; 92(9):1644-9. PubMed ID: 15856038 [TBL] [Abstract][Full Text] [Related]
27. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients. Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149 [TBL] [Abstract][Full Text] [Related]
28. [A pilot study of combined chemotherapy using methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) for advanced or recurrent gastric cancer]. Yamamura Y; Kodera Y; Kito T Gan To Kagaku Ryoho; 1995 Sep; 22(10):1407-10. PubMed ID: 7668879 [No Abstract] [Full Text] [Related]
29. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer. Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277 [TBL] [Abstract][Full Text] [Related]
30. Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma. Loupakis F; Masi G; Fornaro L; Vasile E; Allegrini G; Fontana E; Granetto C; Salvatore L; Mentuccia L; Andreuccetti M; Cortesi E; Merlano M; Cascinu S; Falcone A Cancer Chemother Pharmacol; 2010 Aug; 66(3):559-66. PubMed ID: 20237927 [TBL] [Abstract][Full Text] [Related]
31. [FOLFOX4 regimen versus DP(O)F regimen for advanced gastric cancer]. Wu F; Zhang HG; Ran FW; Zhang XR; Shi YK Ai Zheng; 2008 Apr; 27(4):413-7. PubMed ID: 18423129 [TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer. Cho YH; Kim SY; Hong Lee M; Yoo MW; Bang HY; Lee KY; Yoon SY Gastric Cancer; 2012 Oct; 15(4):389-95. PubMed ID: 22237658 [TBL] [Abstract][Full Text] [Related]
33. Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group. Cullinan SA; Moertel CG; Wieand HS; O'Connell MJ; Poon MA; Krook JE; Mailliard JA; Tschetter LK J Clin Oncol; 1994 Feb; 12(2):412-6. PubMed ID: 8113849 [TBL] [Abstract][Full Text] [Related]
34. Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis. Takashima A; Shirao K; Hirashima Y; Takahari D; Okita NT; Nakajima TE; Kato K; Hamaguchi T; Yamada Y; Shimada Y J Cancer Res Clin Oncol; 2010 Feb; 136(2):243-8. PubMed ID: 19727819 [TBL] [Abstract][Full Text] [Related]
35. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer. Cho BC; Kim JH; Kim CB; Sohn JH; Choi HJ; Lee YC; Ahn JB Oncol Rep; 2006 Mar; 15(3):621-7. PubMed ID: 16465422 [TBL] [Abstract][Full Text] [Related]
36. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer. Wang F; Wang Z; Zhou N; An X; Xu R; He Y; Li Y Am J Clin Oncol; 2011 Aug; 34(4):401-5. PubMed ID: 21791984 [TBL] [Abstract][Full Text] [Related]
37. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group. Oechsle K; Bokemeyer C; Hartmann JT; Budach W; Trarbach T; Stahl M; Boehlke I; Kollmannsberger C; J Cancer Res Clin Oncol; 2009 Feb; 135(2):163-72. PubMed ID: 18825411 [TBL] [Abstract][Full Text] [Related]
38. Infusional 5-fluorouracil and mitomycin C: an effective regimen in the treatment of advanced gastric cancer. Rudi J; Werle S; Bergtholdt D; Hofheinz RD Onkologie; 2005 Mar; 28(3):128-32. PubMed ID: 15772462 [TBL] [Abstract][Full Text] [Related]
39. 5-fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma. Loehrer PJ; Harry D; Chlebowski RT Invest New Drugs; 1994; 12(1):57-63. PubMed ID: 7960608 [TBL] [Abstract][Full Text] [Related]